Clinical Trial Report

Dose–response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT)

Beeh KM, Emirova A, Prunier H, Santoro D, Nandeuil MA

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1701-1711

Published Date: 25 May 2018